​

Spruce Biosciences (SPRB) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

SPRB Stock Rating

Spruce Biosciences stock's rating consensus is Buy, based on 5 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 5 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 5 0 5 Strong Sell Sell Hold Buy Strong Buy

SPRB Price Target Upside V Benchmarks

TypeNameUpside
StockSpruce Biosciences-
SectorHealthcare Stocks 25.10%
IndustryBiotech Stocks 61.24%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$0.41$0.41$0.41
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Feb, 25--5--5
Jan, 25--5--5
Dec, 24116--8
Nov, 24115--7
Oct, 24115--7
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Dec 02, 2024OppenheimerOutperformOutperformhold
Jun 13, 2024OppenheimerOutperformOutperformhold
Mar 14, 2024JMP SecuritiesMarket OutperformMarket Outperformhold
Sep 08, 2023SVB LeerinkOutperformupgrade
Sep 08, 2023MoffettNathansonOutperformupgrade
Mar 23, 2023JefferiesBuyBuyhold
Nov 16, 2022JMP SecuritiesMarket Outperforminitialise
Dec 20, 2021OppenheimerOutperforminitialise

Financial Forecast

EPS Forecast

Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-1.24-----
Avg Forecast$-1.40$-0.93$-0.57$-0.62$-0.93$-1.01
High Forecast$-1.30$-0.84$-0.41$-0.15$-0.33$-0.35
Low Forecast$-1.50$-1.07$-0.68$-1.09$-1.53$-1.66
Surprise %-11.43%-----

Revenue Forecast

$0 $6M $12M $18M $24M $30M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$10.09M-----
Avg Forecast$8.53M$5.09M$900.00K$8.25M$10.75M$19.50M
High Forecast$9.97M$5.60M$1.35M$12.38M$16.13M$29.25M
Low Forecast$7.40M$4.51M$450.00K$4.13M$5.38M$9.75M
Surprise %18.29%-----

Net Income Forecast

$-65M $-53M $-41M $-29M $-17M $-5M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-47.92M-----
Avg Forecast$-53.79M$-39.43M$-25.61M$-36.13M$-35.81M$-38.70M
High Forecast$-49.97M$-32.37M$-15.75M$-5.65M$-12.54M$-13.55M
Low Forecast$-57.60M$-41.36M$-26.34M$-41.84M$-59.09M$-63.86M
Surprise %-10.91%-----

SPRB Forecast FAQ

Is Spruce Biosciences stock a buy?

Spruce Biosciences stock has a consensus rating of Buy, based on 5 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 5 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Spruce Biosciences is a favorable investment for most analysts.

What is Spruce Biosciences's price target?

Spruce Biosciences's price target, set by 5 Wall Street analysts, averages - over the next 12 months. The price target range spans from - at the low end to - at the high end, suggesting a potential 0% change from the previous closing price of $0.41.

How does Spruce Biosciences stock forecast compare to its benchmarks?

Spruce Biosciences's stock forecast shows a 0% downside, underperforming the average forecast for the healthcare stocks sector (25.10%) and underperforming the biotech stocks industry (61.24%).

What is the breakdown of analyst ratings for Spruce Biosciences over the past three months?

  • February 2025: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.
  • January 2025: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 12.50% Strong Buy, 12.50% Buy, 75.00% Hold, 0% Sell, 0% Strong Sell.

What is Spruce Biosciences’s EPS forecast?

Spruce Biosciences's average annual EPS forecast for its fiscal year ending in December 2024 is $-0.93, marking a -25.00% decrease from the reported $-1.24 in 2023. Estimates for the following years are $-0.57 in 2025, $-0.62 in 2026, $-0.93 in 2027, and $-1.01 in 2028.

What is Spruce Biosciences’s revenue forecast?

Spruce Biosciences's average annual revenue forecast for its fiscal year ending in December 2024 is $5.09M, reflecting a -49.52% decrease from the reported $10.09M in 2023. The forecast for 2025 is $900K, followed by $8.25M for 2026, $10.75M for 2027, and $19.5M for 2028.

What is Spruce Biosciences’s net income forecast?

Spruce Biosciences's net income forecast for the fiscal year ending in December 2024 stands at $-39.427M, representing a -17.72% decrease from the reported $-47.919M in 2023. Projections indicate $-25.613M in 2025, $-36.125M in 2026, $-35.815M in 2027, and $-38.703M in 2028.